指南与共识慢阻肺

GOLD 2017 慢阻肺诊断、管理和预防全球策略执行摘要

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary.
指南 / 共识 · Am J Respir Crit Care Med · 2017-01-01

GOLD 2017 报告执行摘要聚焦修订与新增内容:慢阻肺评估将肺功能检查与症状评估分离,ABCD 分组仅依据症状和急性加重史;提出各组药物升级策略并引入降阶梯治疗概念;全面阐述非药物治疗并强调合并症管理的重要性。

要点

  • ABCD 分组仅依据症状和急性加重史,肺功能独立评估。
  • 各组提出药物升级策略,并引入降阶梯治疗概念。
  • 强调非药物治疗及合并症管理在慢阻肺管理中的重要性。

核心结论

  • GOLD 2017 修订慢阻肺评估体系,将肺功能检查与症状评估分离,ABCD 分组仅依据症状和急性加重史。
  • 报告提出各组药物升级策略并引入降阶梯治疗概念,同时全面阐述非药物治疗和合并症管理的重要性。

研究设计与样本

  • 全球慢性阻塞性肺疾病倡议(GOLD)2017 报告执行摘要,聚焦文档修订与新增部分。

主要发现

  • 慢阻肺评估细化,肺功能检查与症状评估分离,ABCD 分组仅依据症状和急性加重史。
  • 针对 A 至 D 各组提出药物治疗升级策略,并引入降阶梯治疗概念。
  • 全面阐述非药物治疗,并综述合并症在慢阻肺管理中的重要性。

临床怎么用

  • 临床可按症状和急性加重史进行 ABCD 分组,肺功能独立评估。
  • 药物治疗可参考各组升级策略,并考虑降阶梯治疗。
  • 管理慢阻肺时应重视非药物治疗和合并症评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

This Executive Summary of the Global Strategy for the Diagnosis, Management, and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 report focuses primarily on the revised and novel parts of the document. The most significant changes include: (1) the assessment of chronic obstructive pulmonary disease has been refined to separate the spirometric assessment from symptom evaluation. ABCD groups are now proposed to be derived exclusively from patient symptoms and their history of exacerbations; (2) for each of the groups A to D, escalation strategies for pharmacologic treatments are proposed; (3) the concept of deescalation of therapy is introduced in the treatment assessment scheme; (4) nonpharmacologic therapies are comprehensively presented; and (5) the importance of comorbid conditions in managing chronic obstructive pulmonary disease is reviewed.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary. Am J Respir Crit Care Med. 2017. PMID: 28128970. doi:10.1164/rccm.201701-0218PP

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。